stella
beta
Sacituzumab Govitecan in Recurrent Glioblastoma — Stella
Recruiting
Back to Recurrent Glioblastoma trials
Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
Trial locations
(3 sites)
United States
Cleveland Clinic Taussig Cancer Center, Cleveland, Ohio
Texas Oncology Austin, Austin, Texas
University of Texas Health Science Center San Antonio at the Cancer Therapy and Research Center, San Antonio, Texas
View full record on ClinicalTrials.gov